Weil Company, Inc. Amgen Inc Transaction History

Weil Company, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $276,718 - $306,123	-1,262 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $250,986 - $287,231	1,262 New	1,262 $284,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $526,085 - $585,049	-2,242 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $53,408 - $65,539	-270 Reduced 10.75%	2,242 $529,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $18,952 - $25,136	-104 Reduced 3.98%	2,512 $509,000

Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $95,740 - $123,059	-506 Reduced 16.21%	2,616 $631,000
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $6,668 - $7,816	40 Added 1.3%	3,122 $575,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $180,870 - $203,880	-1,000 Reduced 24.5%	3,082 $586,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $689,000 - $769,824	4,082	4,082 $710,000

2,932

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Weil Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Weil Company, Inc. with notifications on news.